Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2025 Jun 6.
Published in final edited form as: Structure. 2024 Mar 21;32(6):725–738.e8. doi: 10.1016/j.str.2024.02.022

Stabilization of F-actin by Salmonella effector SipA resembles the structural effects of inorganic phosphate and phalloidin

Ewa Niedzialkowska 1,#, Lucas A Runyan 2,#, Elena Kudryashova 2, Edward H Egelman 1,*, Dmitri S Kudryashov 2,3,*
PMCID: PMC11162321  NIHMSID: NIHMS1977197  PMID: 38518780

Summary:

Entry of Salmonella into host enterocytes relies on its pathogenicity island 1 effector SipA. We found that SipA binds to F-actin in a 1:2 stoichiometry with sub-nanomolar affinity. A cryo-EM reconstruction revealed that SipA’s globular core binds at the grove between actin strands, whereas the extended C-terminal arm penetrates deeply into the inter-strand space, stabilizing F-actin from within. The unusually strong binding of SipA is achieved by a combination of fast association via the core and very slow dissociation dictated by the arm. Similarly to Pi, BeF3, and phalloidin, SipA potently inhibited actin depolymerization by ADF/cofilin, which correlated with increased filament stiffness, supporting the hypothesis that F-actin’s mechanical properties contribute to the recognition of its nucleotide state by protein partners. The remarkably strong binding to F-actin maximizes the toxin’s effects at the injection site while minimizing global influence on the cytoskeleton and preventing pathogen detection by the host cell.

Keywords: actin, SipA, cryo-EM, actin-specific toxins, Salmonella

Graphical Abstract

graphic file with name nihms-1977197-f0001.jpg

eTOC blurb

Niedzialkowska et al. report F-actin interaction with Salmonella SipA effector. The 1:2 binding stoichiometry is bestowed by a competition between the Core and flexible Arm2 domains. While Core enables initial docking, a subsequent Arm2 insertion between actin strands drastically slows SipA dissociation, increases filament stiffness, and cooperatively inhibits depolymerization by ADF.

Introduction

Pathogenic Enterobacteriaceae are the leading cause of enteric and diarrheal diseases. The World Health Organization (WHO) estimates that Salmonella spp., Shigella spp., and Escherichia coli cause ~380–1,360 million enteric illnesses and ~350,000–920,000 deaths yearly worldwide1. Moreover, the emergence of multi-antibiotic resistance among these Enterobacteriaceae is a pressing concern in healthcare settings throughout the world, urging the development of new treatments to combat these pathogens. Understanding how Enterobacteriaceae invade host cells opens new targets for designing antimicrobial drugs.

SipA is a 74-kDa protein from Salmonella spp. that is encoded by Salmonella pathogenicity island 1 (SPI-1) and delivered to the host cell by type III secretion system 1 (T3SS1)2. Once recognized as a protein with a secondary role in Salmonella invasion whose function is to retain the bacterium at the host cell3,4, SipA has been recently reinstated as the most critical factor for invasion into polar epithelial cells under physiological conditions5. In contrast to the actin ruffle-dependent invasion of the pathogen into non-polar cultured cells that heavily depends on the injection of SopB, SopE and SopE2 effectors3, entry into polarized epithelial cells relies on SipA-dependent localized actin cytoskeleton rearrangements near the entry site5. The detailed role of SipA in this process and its ability to manipulate actin dynamics remains obscure.

SipA contains two well-defined globular α-helical N- (residues 48–264) and C-terminal (residues 512–658) domains flanked by disordered regions of various lengths6,7 (Figure 1A). SipA’s N-terminal domain contains a bacterial chaperone InvB-binding region (residues 27–264) that facilitates translocation7 through the T3SS1 apparatus. This region encompasses the foci-forming F1 domain (residues 170–271)8, which contains the soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE)-like peptide (residues 180–232) involved in remodeling of early endosomes9. This functional domain is followed by the sequence that stimulates transepithelial migration of polymorphonuclear leukocytes (residues 294–424)10, substantially overlapping with the SipA self-association domain (residues 280–394)8. SipA has been shown to activate caspase 3, which cleaves the toxin after Asp435 into N- and C-terminal fragments (SipAN and SipAC, respectively)11,12. SipAC interacts with F-actin6 and contains a globular core domain (residues 512–658) flanked by flexible N- and C-terminal regions, hereafter designated as Arm1 and Arm2, respectively (Figure 1A). F-actin saturated with SipA has a lower critical concentration and is resistant to severing and depolymerization by actin depolymerizing factor (ADF)/cofilin13,14.

Figure 1. Cryo-EM reconstruction revealed nearest-neighbor exclusion of SipAC on F-actin and minor perturbations to actin structure.

Figure 1.

(A) SipA domain schematic; numbers represent amino acids in the SipA sequence (UniProtID: P0CL52). InvB, bacterial chaperone InvB-binding region (a.a. 27–264); F1, foci-forming domain (a.a. 170–271); SNARE, SNARE-like peptide (a.a. 180–232); PMN migration, stimulates transepithelial migration of polymorphonuclear leukocytes (a.a. 294–424); Self-association, SipA self-association domain (a.a. 280–394); Core, globular core domain (a.a. 512–658); Arm 1 and Arm2, disordered regions flanking the Core (a.a 425–511 and 660–685, respectively).

(B) Cryo-EM density map of an actin filament (in grey) decorated by SipAC (in magenta) (EMD-42161).

(C) Superposition of bare actin (blue; PDB ID: 8D14) with SipAC/F-actin complex (SipAC in magenta, actin monomer in cyan, F-actin density in grey) highlights changes in D-loop conformation (black arrow).

(D) Zoomed-in view of the D-loop region: the D-loop of protomer n+1 (cyan) is displaced 4.7 Å upon SipAC binding, relative to bare actin (blue). Displacement is measured between Cα atoms of actin Gly48.

The actin cytoskeleton is a highly dynamic system that mediates various cellular processes, such as cell motility, adhesion, intracellular transport, membrane remodeling, and contractile ring closure during cell division15. Monomeric actin (G-actin) polymerizes into filaments (F-actin)16, which can be further assembled into higher-order structures with numerous functionalities17. The balance between G- and F-actin is highly regulated18 and perturbations in G-/F-actin dynamics can be lethal. For example, cyclic peptides phalloidin and jasplakinolide produced by Amanita phalloides and Jaspis spp., respectively19,20, manifest their toxicity by stabilizing F-actin. The key factors that mediate actin recycling are ADF/cofilin isoforms, which induce conformational changes in F-actin, promote its severing and, with the assistance of actin-interacting protein 1 (AIP1) and cyclase associated proteins 1 and 2 (CAP1/2), accelerate F-actin depolymerization2123.

The interaction between the SipA446−684 fragment and F-actin was previously studied using negative-stain electron microscopy (EM), and stapling of the two actin strands with the fragment’s N- and C-terminal nonglobular arms was postulated6. It was suggested that such binding would lead to the increased mechanical stability of the more connected actin strands6,24, but the low resolution of the structure prevented revealing the atomic details of this interaction. To better comprehend the structural mechanisms of actin stabilization by SipA that is critical at early (invasion) and late (maintenance and protection of Salmonella-containing vacuole (SCV)) stages, we analyzed SipA-decorated F-actin using cryo-EM reconstruction and performed detailed biochemical characterization of the SipA/F-actin interaction, particularly at low-molar ratios of SipA to actin relevant for an infected cell.

Results

Cryo-EM revealed a 1:2 stoichiometry and bimodal binding of SipA to F-actin

Our initial attempts to reconstruct F-actin decorated by SipA425−685 (hereafter, SipAC) assuming a 1:1 ratio to actin were complicated by lower density for the toxin compared to actin, which translated into less than 50% SipAC occupancy. Visual inspection of the map revealed continuous density arising from SipAC that was connected between adjacent binding sites, which must be artifactual. At a 1:1 stoichiometry, the manually built C-terminal tail of SipA (Arm2) generated steric clashes with the globular domain of the next SipAC in the adjacent binding site, prompting us to redo the reconstruction assuming a 1:2 ratio. A 3D variability analysis (3DVA) algorithm25 was applied to 2D classified particles followed by a round of 3D classification. Particles from a 3D class with no steric clashes between SipA molecules were refined with a 112.075 Å rise and −306.344° rise, corresponding to an asymmetric unit containing four actin subunits and two SipAC molecules. Ultimately, non-uniform refinement was performed on 1,548,993 particles after the position and orientation of volumes and particles were adjusted with helical parameters 112.075 Å rise and −306.344° twist (Figure S1). The resulting 3.2 Å map (Figure 1B, Figure S2A,B) contained well-defined density for almost all of actin and most of SipAC with the resolution decreasing towards the periphery (Figure S2C,D). The C-terminal Arm2 could now be easily traced in the density extending from the globular domain without steric clashes with other SipAC subunits.

The SipAC-decorated filament closely resembles the naked ADP-Pi actin (PDBID: 8D1426; RMSD 0.4 Å), and we were able to model ADP, inorganic phosphate (Pi), and Mg2+ in the nucleotide-binding cleft (Figure S3A). The only difference was in the position of the DNaseI-binding loop (D-loop; Figure 1C,D and Figure S3C), a highly dynamic, nucleotide-sensing element involved in establishing short- and long-pitch contacts in F-actin and in binding to several actin-binding proteins27. Binding of SipAC caused a ~5-Å displacement of Gly48 in the D-loop compared to a naked reconstruction of ADP-Pi actin (PDBID: 8D14; Figure 1D).

The SipAC construct used for cryo-EM reconstruction comprises an N-terminal unstructured arm (residues 425–511; Arm1), a globular region (residues 512–658; Core) composed of five helices linked by short loops, and a 26-residue C-terminal arm (residues 659–685; Arm2). Arm1 was not seen in the density, presumably due to disorder. Four of the Arm2 amino acids (residues 669 – 672) were only partially visible in the reconstruction. The globular domain of SipAC bridges actin subunits both along the same strand and across the opposite strands. Counting from the barbed end of the actin filament, the SipAC-Core is nested between subdomain 4 of protomer n, subdomains 1 and 2 of n+1, subdomains 3 and 4 of n+2, and subdomain 1 of n+3 (Figure 2A). The actin-binding interface in the Core is formed by ionic interactions between actin Asp80 of protomer n+1 and Arg551 of SipAC (Figure 2B). Actin Glu224 and Glu316 of protomer n+2 form salt bridges with Arg628 and Lys618 of SipAC (Figure 2C,D). The SipAC/F-actin interface is also stabilized by hydrophobic interactions between Phe266 of actin n+2 and Val532 of SipAC (Figure 2E) and intimate connections between Met538 and His539 of SipAC and the D-loop of actin n+1 (Figure 2F). Met538 also contributes the side chain to a hydrophobic contact with actin Met355 of protomer n+3 (Figure 2F), enforcing the longitudinal interprotomer contacts in F-actin. Among other D-loop contacts, the side chain of actin Gln41 is within a hydrogen bond distance from the carbonyl group of SipA’s His536, while the carbonyl of Val45 and side chain of Gln49 may form hydrogen bonds with His539 of SipA, assuming the latter is protonated (Figure 2F).

Figure 2. SipAC binds actin via two distinct regions, the Core and Arm2.

Figure 2.

(A) Atomic model fit to SipAC-decorated-actin cryo-EM density (EMD-42161). SipAC (ribbon representation, magenta) contacts five actin protomers (cylinder representation, colored by protomer, numbered from the barbed end from n to n+4). Dashed box indicates SipAC-Core, whose interaction with actin is detailed in panels B-F.

(B) Actin protomer n+1 residue Asp80 forms ionic bonds with Arg551 on SipAC.

(C) Actin protomer n+2 residues Glu224 and Glu316 form ionic interactions with Arg628 and Lys618 on SipAC.

(D) Actin protomers n+3 and n+2 contribute ionic interactions from Glu364 and Glu224 to SipAC Lys636 and Arg628 respectively, orienting the placement of Arm2.

(E) Phe226 on actin n+2 is involved in hydrophobic interaction with Val532 of SipAC.

(F) Met538 of SipAC interacts hydrophobically with Met355 on n+3 protomer (white) while His539 H-bonds with carbonyl group of Val45 and Gln49 on n+1 protomer (cyan) in the D-loop. Gln41 forms H-bond with His536.

(G) Overview of SipA/F-actin complex as in A, with the dashed box denoting Arm2-actin interactions (detailed in panels H-I).

(H) Hydrophobic residues Tyr665, Leu666, Val674, and Met683 on SipAC anchor Arm2 to filament inter-strand space. i, Val678 on SipAC contributes to inter-strand interactions by interacting with Val201 on protomer n+2 and Met269 on protomer n+3.

The Arm2 of SipAC binds deep in the inter-strand cleft of F-actin

In our reconstruction, Arm2 is visible as an additional density deep between the two actin strands that cannot be explained by actin protomers or the SipAC-Core (Figure 2G,H). Arm2 extends between the two actin strands and interacts with protomers n+2, n+3 and n+4. The positioning of Arm2 into the inter-strand space is guided by ionic interactions between Arg628 of SipAC and Glu224 of actin n+2, and Lys636 of SipAC and Glu364 of actin n+3 (Figure 2D). Another residue crucial for proper docking of Arm2 is Tyr665, whose side chain points toward the helical axis of the actin filament, anchoring Arm2 between actin protomer n+2 and n+3. Binding of Arm2 is further stabilized by hydrophobic contributions from Leu666, Val674, Val678 and Met683 of SipAC (Figure 2H). Val678 of SipAC appears to be crucial for enforcing inter-strand interactions as it forms hydrophobic interactions with both Met269 of actin protomer n+3 and Val201 of actin protomer n+2 (Figure 2I).

Almost all the residues involved in the interaction with SipAC are conserved between skeletal actin, used in our reconstruction, and the non-muscle actin isoforms. The only exception is Val201 of skeletal actin, which is replaced by Thr201 in cytoplasmic actin. This substitution preserves the environment in the space between actin strands and should not affect SipAC binding (Figure S3B).

SipAC differentially competes with phalloidin and jasplakinolide

Since our structural data contradicted a previously reported 1:1 stoichiometry of SipAC to actin13, we independently confirmed the 1:2 molar stoichiometry in co-pelleting assays (Figure 3A,B). Although the binding mode of SipAC is unique for actin-binding proteins, the binding site of Arm2 within the inter-strand cleft overlaps with those of F-actin stabilizing toxins phalloidin and jasplakinolide (Figure 3C,D)20. This observation prompted us to test whether phalloidin and jasplakinolide compete with SipAC for F-actin. First, we assessed binding of both drugs to actin, using tetramethylrhodamine-isothiocyanate (TRITC)-phalloidin and SiR-actin, the fluorescent derivatives of phalloidin and jasplakinolide, respectively. We found the dissociation constant (Kd) of TRITC-phalloidin binding to F-actin to be 45 nM (Figure 3E) and that of SiR-actin to be 20 nM (Figure 3F). Next, in competition experiments with SiR-actin, both SipAC and SipAC-Core were able to fully displace jasplakinolide from actin, suggesting the competition of the drug with both Core and Arm2 (Figure 3G,H). SipAC construct competed notably more effectively, with Kd values derived from the binding isotherm competition equation being 0.18 nM and 81 nM, for SipAC and SipAC-Core respectively (Figure 3G). In competition with TRITC-phalloidin, SipAC-Core failed to displace the drug from actin (Figure 3I), while SipAC displaced only about half of the drug (Figure 3J) with an apparent Kd of 5 nM (Figure 3I), in agreement with i) 1:2 stoichiometry and ii) only the Arm2 and not the globular Core domain competing with phalloidin.

Figure 3. Arm2’s binding site on F-actin overlaps with those of phalloidin and jasplakinolide.

Figure 3.

(A,B) Binding stoichiometry of SipAC to F-actin was determined in co-sedimentation experiments.

(A) A representative SDS-PAGE co-sedimentation gel, where S and P designate supernatant and pellet fractions.

(B) Relative molar content of SipAC to actin in the pellet fractions plotted as mean values ± SD from three technical replicates.

(C) An overview (left) and zoomed-in view (right) of the inter-strand space in the vicinity of SipAC-Arm2-binding site, showing overlap between Arm2 (magenta), phalloidin (green; PDB ID: 6T1Y) and jasplakinolide (yellow; PDB ID: 6T24).

(D) Light grey indicates density around actin residues that do not participate in SipA binding; light pink – density around residues that interact with SipA, but not with phalloidin or jasplakinolide; purple – density around residues that interact with both SipA and phalloidin/jasplakinolide; blue – density around residues that interact with phalloidin or jasplakinolide, but not with SipA. The C-terminal tail of SipA is in magenta.

(E) FA analysis of TRITC-phalloidin binding to actin.

(F) FI analysis of SiR-actin binding to actin.

(G) Normalized FI competition data for SiR-actin with SipAC or SipAC-Core.

(H) Raw FI data for SiR-actin binding to F-actin and competition with unlabeled SipAC.

(I) Normalized FA competition data for TRITC-phalloidin with SipAC or SipAC-Core.

(J) Raw FA data for TRITC-phalloidin binding to actin and competition with unlabeled SipAC show that only ~50% of TRITC-phalloidin is displaced by SipAC. All data are presented as the average of three technical replicates, error bars show standard deviation (SD) between replicates.

Equilibrium binding revealed distinct roles of SipAC domains in binding to actin

To reveal the roles of Core, Arm1, and Arm2 in SipAC binding to actin, we conducted direct and competition fluorescence anisotropy measurements with fluorescein maleimide (FM)-labeled SipAC, SipAC-ΔArm2 and SipAC-Core constructs (Figure S4A). Identical, except unlabeled, constructs were used in the competition experiments. The presence of Arm2 notably increased the affinity of the toxin to actin (e.g., compare ~0.9 nM and 120 nM Kds for the labeled SipAC and SipAC-ΔArm2, respectively; Table S1 and Figure S4BE). In contrast, the presence of Arm1, which was disordered in the cryo-EM reconstruction, decreased the binding strength of SipAC by a factor of ~4–10, depending on the experimental approach (Table S1 and Figure S4DG). This inhibition is likely due to the entropic cost of Arm1’s restricted flexibility in the actin-bound state. Competition experiments overall confirmed these findings while showing even higher affinities of the unlabeled constructs for actin (Figure S4E,G). Measuring these high affinities necessitated dropping actin concentrations below its critical concentration for polymerization (CC ~100 nM). To overcome this challenge, the ΔArm2 constructs (i.e., SipAC-Core and SipAC-ΔArm2, which do not compete with phalloidin) were titrated with phalloidin-stabilized actin, while the SipAC construct (competes with phalloidin but also potently stabilizes F-actin) was titrated by free F-actin upon its rapid dilution from concentrations above critical. Since such limitations and variations are vulnerable to inaccuracies, and to get further insight into the contribution of SipAC domains to F-actin binding, we reassessed the binding by measuring its kinetic characteristics.

Kinetic experiments suggest a bimodal “docking-then-anchoring” binding of SipAC to actin

We monitored changes in anisotropy of FM-labeled SipAC constructs upon their binding to or competitive dissociation from F-actin using a stopped-flow fluorometer (Figure 4). Each SipAC construct had a linear dependence of kobs on F-actin, yielding kon values within a ~3-fold range of each other (Figure 4A and Table S1). SipAC-ΔArm2 had the lowest association rate of 1.4 μM−1s−1, which increased to 3.7 μM−1s−1 upon removal of Arm1. The presence of Arm2 accelerated binding to 3.8 μM−1s−1 even in the presence of Arm1, thereby compensating for the binding deficiency caused by Arm1. Interestingly, Arm2 alone, synthesized as a peptide with an N-terminal fluorescein isothiocyanate (FITC) label, failed to bind actin in anisotropy experiments. Additionally, the Arm2-only constructs showed diffuse localization upon expression in cells (Figure 5) regardless of the fluorescent protein tag location (Figure 5A,H,I). Taken together, these results demonstrate the critical role of the globular core domain in the initial docking of SipA to F-actin.

Figure 4. Association and dissociation rates of SipAC are dictated by the Core and Arm2 domains, respectively.

Figure 4.

(A) The kobs values determined from kinetic association experiments plotted against actin concentration show a linear relationship and yield kon values for each SipAC construct; error bars represent the curve fit error. Data are presented as the average of at least 10 time courses.

(B,C) Dissociation kinetics of FM-SipAC (B), FM-SipAC-ΔArm2 and SipAC-Core (C) from F-actin upon competition with excess of respective unlabeled constructs yields koff values for each construct. Grey traces represent fits to a single exponential. Data are presented as the average from either four (B) or at least 10

(C) time courses.

(D) Schematic of TIRFM experiments to monitor dissociation of SipAC from F-actin.

(E) Representative images from TIRFM dissociation experiments. White arrows indicate Alexa-647 SipAC molecules present throughout the experiment duration from t = 0 s (left) to t = 7200 s (right); yellow arrowheads indicate Alexa-647 SipAC molecules present at t = 0 s but not at t = 7200 s. Scale bars are 10 μm.

(F) Dissociation of Alexa-647 labeled SipAC from Alexa-488 labeled F-actin in TIRFM corrected for photobleaching was fit to a single exponential decay equation providing an estimate of koff, which yields a Kd of ~100 pM. All koff (B,C,F) values are reported with curve fit error. Data are presented as the average of four independent experiments.

Figure 5. Intracellular localization of SipA constructs.

Figure 5.

(A) Domain schematics of SipA constructs used for transfections.

(B-I) Representative maximum intensity projection images of Z-stacks of U2OS cells co-transfected with the SipA constructs and F-tractin (to visualize actin). Scale bars are 10 μm.

In a classical experimental design described above, the dissociation rate constants (koff) was determined by adding an unlabeled competitor to the complex of the labeled molecule (e.g., FM-SipAC) and its partner (e.g., actin). The competitor must be added in a sufficient, empirically determined excess to prevent reassociation of the studied molecule after its spontaneous dissociation. While this method provides reliable outcomes for simple, single-domain interactions (e.g., SipAC-Core with actin), it typically reports overestimated rates for more complex situations when two or more domains are involved28. With these limitations in mind, we determined that the constructs missing Arm2 showed similar dissociation rate constants (koff) of 0.39 and 0.59 s−1, whereas SipAC displayed a 150-fold slower rate of 3.04 × 10−3 s−1 (Figure 4B,C). Yet, even this slow rate is likely to be overestimated as the competition with the unlabeled protein erases the key property of dual valency/avidity interactions. Indeed, in avidity interactions involving two or more binding sites, the dissociation of one of the domains is more likely to be followed by its reassociation than by the dissociation of the entire complex28. Instead, the excess of unlabeled SipAC takes the place of the dissociated domain, preventing its rebinding and resulting in much faster dissociation rates overall.

To address this experimental deficiency, we directly measured the dissociation of SipAC by counting the drop in actin-associated Alexa-647-SipAC molecules by taking snapshots in 20-minute intervals for 2.5 hours in TIRF microscopy experiments (Figure 4DF). Fitting of the results to single or dual exponential decay revealed that 60% of Alexa-647-SipAC molecules showed no detectable dissociation during the span of the experiment, while the remaining 40% dissociated with the koff of 3.8 × 10−4 s−1, resulting in an equilibrium dissociation constant of 100 pM (Figure 4C). The koff of SipAC is similar to that of phalloidin29, but the overall binding of SipAC is ~170 fold stronger mostly due to much slower association rate of phalloidin (0.028 μM−1s−1)29 as compared to SipAC (3.8 μM−1s−1). This comparison reveals the importance of both the Core and Arm2 domains in attaining this unprecedented interaction strength by “docking” (via Core) and “anchoring” (via Arm2) SipAC to actin. Whereas the former provides fast association, the latter ensures slow dissociation, resulting in the unique actin-binding properties of SipAC.

The detected fast binding and remarkably slow dissociation from actin explains the localization of SipA at the site of injection by Salmonella, as SipA’s diffusion inside the host cell is expected to be negligible under such conditions. Accordingly, all SipA constructs containing both the Core and Arm2 actin-binding domains were localized in actin-enriched compact foci (Figure 5B,D,E), likely depicting the sites of their synthesis on ribosomes. Besides the sites of SipA localization, the geometry of actin fibers in such cells was not substantially affected. The constructs lacking both actin-binding domains or containing only Arm2 showed diffused localization (Figure 5C,H,I). Interestingly, the SipAC-Core domain lacking Arm2 localized along actin fibers throughout the entire cell area, notably perturbing the geometry of the actin cytoskeleton (Figure 5F). Finally, an artificial construct containing two tandem SipAC-Core domains induced profound bundles primarily in the perinuclear area of the cells (Figure 5G). Therefore, the unique contribution of both Core and Arm2 ensures compact SipA localization and limits the generalization of its toxic effects within the cell.

Arm2 enables cooperative stabilization of actin by SipAC

To evaluate how such strong binding may affect the dynamics of actin and its actin-binding partners, we explored the thermal stability of F-actin and its depolymerization/severing by ADF. It is known that stoichiometric doses of SipA protect F-actin against depolymerization by cofilin14. Yet, given the abundance of actin in the cell, stoichiometric toxin concentrations cannot be considered physiological and are insufficient for understanding the pathogenesis3032. We found that the SipAC constructs containing Core but lacking Arm2 caused no stabilization of actin in thermal denaturation experiments (Figure 6A). In contrast, SipAC raised the melting temperature of F-actin by ~ 6 °C, as compared to ~ 10 °C stabilization by phalloidin (Figure 6A). The observed stronger actin stabilization by phalloidin was likely due to two factors. First, 1:1 stoichiometry of phalloidin to actin enforces the inter-strand connections between all actin subunits. Second, a lower thermal stability of SipAC may prevent actin stabilization at higher temperatures.

Figure 6. Arm2 of SipAC mimics the effects of phalloidin on actin stabilization.

Figure 6.

(A) Effects of bound SipAC constructs or phalloidin on melting temperature (Tm) of F-actin measured by differential scanning fluorimetry.

(B-D) Inhibition of ADF-stimulated actin depolymerization by various concentrations of SipAC (B), SipAC-ΔArm2 (C), and phalloidin (D).

(E,F) Data shown in B-D were quantified as single-exponential decay rates (E) or initial depolymerization rates (F) and plotted against toxin concentration. Lines represent double exponential decay fits for SipA and phalloidin, and linear fits for SipAC-ΔArm2. Error bars represent SD of the mean (A-F).

(G,H) F-actin severing analysis (see Table S2).

(G) Representative TIRF microscopy images of F-actin severed in the presence of ADF alone (top panels), or ADF and SipAC (bottom panels). Scale bars are 10 μm.

(H) Quantification of severing events plotted over time, from 9 TIRF chamber locations (n = 9); error bars represent SE of the mean. Data shown in (A-F) are presented as the average of at least three technical replicates, with error bars representing SD of the mean.

In the cell, F-actin depolymerization is indispensable for proper actin dynamics and is mediated largely by ADF/cofilin proteins and their partners. In reconstituted ADF-mediated actin depolymerization experiments using pyrene-labeled actin (Figure 6BF), the protective effects of SipAC and phalloidin were observed at the lowest tested (1:400) mole ratio to actin, while 50% inhibition (IC50) of depolymerization was achieved at 1:36 and 1:133 mole ratios, respectively (Figure 6B,D,F). Like in the thermal denaturation experiments (Figure 6A), the effects of phalloidin were similar but more pronounced, leading to overall slower depolymerization rates throughout the entire range of toxin concentrations. In both cases, the inhibition of depolymerization was clearly biphasic and could be fit well to dual exponential decay equations (Figure 6E). Notably, the SipAC-ΔArm2 construct caused much less inhibition of depolymerization with a single slope reminiscent of that of the second component in the stabilization curves by phalloidin and SipAC (Figure 6E).

Since the accelerated depolymerization by ADF is a function of both the faster dissociation of subunits from the filament end, and a larger number of ends produced due to severing, we directly assessed severing of F-actin by ADF in total internal reflection fluorescence microscopy (TIRFM) experiments (Figure 6G,H). To explore the severing of actin filaments homogeneously decorated by SipAC at the desired levels of saturation, the construct was incubated with pre-polymerized aged F-actin prior to applying the mixture into the TIRFM chamber. At a 1:200 mole ratio to actin (5 nM SipAC, 1 μM actin), SipAC caused no measurable protection against severing by ADF (Figure 6H, Figure S5, Table S2). However, when SipAC was present at a 1:20 mole ratio to actin (50 nM SipAC, 1 μM actin), decoration of actin by SipAC reduced actin severing by ADF to nearly background levels (Figure 6G,H, Figure S5, Video S1, and Table S2), pointing to a notable cooperativity of the protective effect.

Arm2 of SipAC cooperatively increases F-actin stiffness

Partial decoration of F-actin by SipAC may inhibit depolymerization at the filament ends due to the “capping” effect when the filament is shortened down to the nearest toxin-bound actin subunit. The inhibition of severing by sub-stoichiometric doses of SipAC, however, is less expected as it requires the effects of SipAC binding to propagate to undecorated actin subunits. In the absence of obvious structural differences between ADP-Pi vs ADP actin filaments, a difference in their stiffness was recently proposed to account for a striking difference in their affinities for ADF/cofilin26. To explore whether the observed cooperative inhibition of depolymerization by ADF may have a similar nature, we measured the stiffness (expressed as persistence length (Lp)) of actin filaments in their different nucleotide states and upon interaction with SipAC. For the filaments stabilized during their polymerization (ADP-Pi enriched, young filaments), saturating concentrations of SipAC raised the Lp from 14.6 to 22.5 μm, while SipAC-ΔArm2 only modestly increased Lp to 15.7 μm (Figure 7A, Table S3). Similarly, SipAC increased Lp of pre-polymerized actin filaments (ADP-enriched, aged actin) from 12 to 17.7 μm, which is comparable to the effect of phalloidin (17.8 μm) and notably stronger than the stabilization by a Pi-mimic beryllium trifluoride (BeF3; 13.8 μm) (Figure 7B). Importantly, the concentration dependence of the rise in stiffness caused by SipAC correlated with that of the protection against depolymerization by ADF (Figure 7B,C). This finding supports the hypothesis that the nucleotide-dependent binding of ADF/cofilins to F-actin may be controlled by the difference in stiffness between the ADP-Pi and ADP actin states26.

Figure 7. SipAC increases actin filament stiffness.

Figure 7.

(A,B) Persistence length (Lp) of actin filaments was measured as described in the Methods, and significant differences between average Lp values were determined by ANOVA analysis (see Table S3). These data are presented as the average from at least 30 individual actin filaments; error bars represent SD of the mean.

(C) Lp of ADP-actin (red) and the initial rates of depolymerization from Figure 6F (black) were plotted as functions of actin filament saturation by SipAC, assuming the 2:1 binding stoichiometry. Error bars represent SD of the mean.

SipAC moderately accelerates actin polymerization and strongly inhibits Pi release

Given the ability of a single SipAC molecule to bridge up to five actin subunits, the toxin may stabilize actin nuclei during the nucleation process and thus promote polymerization. Also, the increased filament stiffness may affect the release of inorganic phosphate (Pi) due to reduced thermal fluctuations. Since SipAC binding to pyrene-labeled actin quenches its fluorescence, we opted to measure actin polymerization by light scattering. Both SipAC and SipAC-ΔArm2 similarly promoted polymerization, suggesting that the stabilization of actin nuclei is dominated by fast binding of the Core (Figure 8A). While both constructs also slowed the Pi release from polymerizing actin, the inhibition caused by SipAC was notably stronger. Therefore, while the modest acceleration of polymerization is largely due to SipAC-Core, the inhibition of Pi release is dominated by the effects from Arm2. As the result of these two effects, actin filaments polymerized in the presence of SipAC retain the ADP-Pi state longer than either naked filaments or even SipAC-ΔArm2-decorated filaments (Figure 8B), which explains the well-defined density of Pi in our reconstruction of SipAC-decorated actin (Figure S3A).

Figure 8. SipAC accelerates actin polymerization and inhibits Pi release.

Figure 8.

(A) Actin polymerization (light shade dotted curves) and Pi release (dark shade solid-line curves) in the absence or presence of SipAC and SipAC-ΔArm2. Inset emphasizes the early time points of the graphs.

(B) The fraction of filamentous actin in the ATP and ADP-Pi states was calculated by subtracting the normalized Pi release curves from actin polymerization curves (see STAR Methods). Each curve is the average of at least two independent experiments, and error bars represent SD of the mean.

Discussion

In this work, we discovered that binding of Salmonella effector SipA to F-actin represents a novel mode of actin interaction with its partners. Our atomic model based on the 3.2-Å resolution cryo-EM reconstruction indicates that SipA binds F-actin via extensive interactions with both the C-terminal globular Core domain and flexible Arm2. These contacts endow SipAC with a picomolar Kd for F-actin, which is stronger than those for most actin-binding proteins with the exception of a heterodimeric barbed-end capping protein CapZ, whose Kd is very similar33. This interaction is granted by i) fast binding via the Core (“docking”) and ii) remarkably slow dissociation due to “anchoring” of SipA on actin via Arm2, penetrating deep into the inter-strand space. Strong binding of phalloidin (and likely jasplakinolide) is also achieved due to slow dissociation34, characteristic for the inter-strand binding mode shared by all three molecules19,20. Yet, a much faster association of SipAC, bestowed by its Core, results in ~170-fold stronger binding, compared to the drugs. Therefore, SipAC overcomes the limited accessibility of the inter-strand space34 by a priming interaction at the filament surface. Notably, Arm2 alone does not appreciably bind to actin (Figure 5H,I), possibly due to a high entropic price for the association of a flexible peptide and a deeper location of the binding surface within the cleft (Figure 3C,D).

An actin-binding domain of Vibrio parahaemolyticus VopV was also reported to compete with phalloidin and was found at the inter-strand space, with partial density localized within the cleft35. However, the low 9.6 Å resolution of the VopV-actin structure precluded accurate modeling of the peptide. The reported nanomolar Kd of the VopV repeat to actin is more like that of phalloidin and jasplakinolide, than SipAC. Whether this difference is due to a weaker external “docking” of VopV’s disordered domain or less deep interaction with the cleft remains to be established.

We confirmed a previous finding that SipAC stabilizes F-actin against depolymerization by ADF/cofilin14. Moreover, we showed that this stabilization extends to physiologically relevant, low stoichiometric ratios of SipA to actin (Figure 6), likely achievable upon actual infection. This stabilization is comparable to that caused by phalloidin, which, together with a much weaker effect of SipAC-ΔArm2, suggests that in both cases ADF/cofilins are inhibited by the peptides bound in the inter-strand space. This space is normally occupied by water molecules that provide discrete hydrophilic interactions, lubricate the contacts, and facilitate mechanical rearrangements required for filament flexibility26. Their replacement by strong inter-strand hydrophobic bridges provided by Arm2 or phalloidin explains the observed filament stiffening and stabilization effects in vitro.

The observed Pi-release inhibition (Figure 8A) can result from filament stiffening by Arm2 or by directly influencing the “back door” actin residues gating the Pi release (i.e., methylated His73me, Gly74, Asn111, Arg177)36, or both. Indeed, Arm2 affects the His73me side chain orientation (Figure S6). The His73 of actin is subjected to posttranslational methylation by SETD3 methyltransferase37. Highly conserved among eukaryotes, N3-methylation of His7337,38 stabilizes the positive charge on histidine, which in turn enhances the dipole electrostatic interactions involving the carbonyl of G158, leading to strengthening of the hydrogen bond between carbonyl of G158 and side chain of His73me. As a result, the G158-V159 peptide bond is polarized, increasing the positive nature of the V159 backbone nitrogen. Such a chain of electrostatic interactions strengthens the V159-γ-phosphate hydrogen bond, that in turn may decrease the hydrolysis rate of ATP bound to F-actin39,40. In the SipA/F-actin complex, this chain of electrostatic interactions and hydrogen bond network around G158 and V159 are disrupted because SipA His682 causes the His73me side chain to rotate. Whether these changes affect ATP hydrolysis rates or Pi dissociation in the decorated filament remains to be found.

In the context of Salmonella infection, the remarkably strong binding to actin prevents diffusion of SipA away from the injection site, while also cooperatively stiffening partially decorated actin filaments, stabilizing them against depolymerization by ADF/cofilin. Combined, these effects enable highly effective local stabilization of the cortical actin by minute amounts of SipA, while also avoiding generalized effects on the actin cytoskeleton. The latter would be essential to prevent early detection of the pathogen by innate immune mechanisms, which can initiate inflammation and programmed cell death, leading to elimination of the pathogen. These speculations are supported by a normal morphology of the cells expressing SipA constructs containing both SipAC-Core and Arm2, which are localized in distinct foci (Figure 5B,D,E), and notably stronger cytoskeletal disturbance in the cells expressing the SipAC-Core missing Arm2 (Figure 5F,G).

Whereas tight binding of SipAC to actin enables highly confined anchorage to the cytoskeleton, similarly effective connection with the bacterium is provided by the F1 domain encompassing residues 170–271, which alone is sufficient to form Salmonella-localized foci during the toxin injection8, but not upon expression in host cells (Figure 5C). The mechanisms behind the formation of these foci remain unclear but likely involve membrane remodeling via association with integral membrane proteins, as an overlapping 180–232 a.a. peptide mimics a host SNARE peptide in establishing contacts with syntaxin-8 to promote fusion with early endosomes9. Both the actin-binding domain and F1 peptide of SipA are essential for the toxin-mediated Salmonella entry8.

SipA interaction with actin does not occlude the binding sites of major ABPs (tropomyosin, myosins, calponin-homology domain proteins, etc.), and thus SipA may involve host actin-binding proteins to support Salmonella invasion. However, host proteins whose binding requires major rearrangement of actin contacts, such as ADF/cofilins, or host proteins that also bind at the groove between actin strands such as the Arp2/3 complex and coronins will likely interfere with SipA binding. SipA has been shown to cooperate with plastin, a versatile host protein involved in crosslinking actin filaments in various types of actin bundles and assemblies41. SipA increases the bundling of actin by plastin and recruits the latter to the site of Salmonella invasion42,43. Superposition of F-actin structures decorated by SipAC and by an actin-binding domain of plastin41,44 shows no steric conflicts between these proteins (Figure S7). Since no direct interaction between SipA and plastin has been detected42, the bundling potentiation is likely mediated by F-actin. The longer and stiffer (and, therefore, straighter) SipA-decorated filaments might be a better substrate for crosslinking by most, if not all, actin-bundling proteins. Finally, SipA may serve as a partner protein that weakens the inhibitory association between actin-binding domains of plastin41, favoring the bundling-competent open state45.

While SipA and, with the above reservations, VopV are the only proteins currently recognized to bind in the cleft between actin strands, a very high affinity and increased filament stability granted by such a mode are likely to be beneficial for specific cytoskeleton compartments of a eukaryotic cell, e.g., non-treadmilling actin bundles of inner ear stereocilia. Importantly, the correlation between filament stiffness and access to the interstrand space provides a previously unrecognized way of sensing the nucleotide state of actin. It is tempting to speculate that these new functional capacities remain unrecognized but are utilized by host actin-binding proteins.

When this work was ready for submission, a competing Cryo-EM study reported the same association mode of SipAC with actin46. While the two works agree on general findings and provide very similar cryo-EM structures of F-actin:SipA complex, our study elaborates on many details of these interactions. Indeed, we quantified the competition of SipAC with phalloidin and jasplakinolide and established the correlation between the increased filament stiffness and its susceptibility to depolymerization and severing by cofilin, particularly at stoichiometric doses of SipAC. Most importantly, we measured that SipAC binds to F-actin with picomolar Kd and established the role of individual domains in this unprecedented binding mechanism.

STAR Methods

Resource availability

Lead contact

All inquiries for information or requests for resources should be directed to the lead contact, Dmitri S. Kudryashov (kudryashov.1@osu.edu).

Materials availability

All materials generated in this study are available from the lead contact upon request.

Data and code availability

The cryo-EM map of SipAC/F-actin has been deposited with accession code EMD-42161 in the EMDB. The coordinates used for EM analysis have been deposited in the PDB with accession code 8UEE. This paper does not report original code. Any additional information required to reanalyze the data reported in this work is available from the lead contact upon request.

Experimental model and Study Participant Details

Cell lines

Human U2OS cells were maintained at 37 °C with 5% CO2 in a humidified incubator in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% FBS, L-glutamine, and penicillin-streptomycin. U2OS cells were authenticated by STR profiling using microsatellite genotyping (GSR OSUCCC) and confirmed to be mycoplasma-negative as determined by PCR per published protocol47.

BL21(DE3)-pLysS E. coli was purchased from Agilent Technologies and used following manufacturer protocols. The details of the use of all cells involved in this work are described below.

Method details

Protein purification

Skeletal actin was purified from rabbit skeletal muscle acetone powder (Pel-Freeze Biologicals) as previously described48 using G-buffer [2 mM Tris-HCl, pH 8.0, 0.2 mM CaCl2, 0.2 mM ATP, 0.5 mM β-mercaptoethanol (β-ME), 0.005% sodium azide]. Actin was stored on ice in G-buffer for no longer than one month with dialysis into fresh G-buffer after two weeks of storage.

SipAC (a.a. 425–685) was cloned into a pGEX vector with an N-terminal glutathione S-transferase tag (GST) followed by a thrombin cleavage site. The recombinant protein was expressed in BL21(DE3)-pLysS E. coli (Agilent Technologies) upon induction with 1 mM isopropyl β-D-1-thiogalactopyranoside (IPTG) overnight at 15°C and purified using glutathione resin (Thermo Fisher). The GST-tag was removed by an on-column cleavage using thrombin (GE Healthcare) at a final concentration of 1 unit/mL. The cleaved SipAC was then passed through a HiPrep 26/60 Sephacryl S-200 HR size-exclusion column (GE Healthcare) using actin polymerization buffer [F-buffer: 10 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), pH 7.0, 100 mM KCl, 2 mM MgCl2, 0.5 mM ethylene glycol-bis(β-aminoethyl ether)-N,N,N′,N′-tetraacetic acid (EGTA), 0.2mM ATP, and 2 mM dithiothreitol (DTT)] that was devoid of ATP. Purified SipAC was flash-frozen in liquid nitrogen and stored at −80 °C.

SipAC-ΔArm2 (a.a. 425 – 658) and SipAC-Core (a.a. 512 – 658) were cloned with an N-terminal 6xHis-tag into pColdI vector (Takara Bio USA) modified to include a tobacco etch virus (TEV) protease recognition sequence downstream of the 6xHis-tag49 using NEBuilder HiFi DNA assembly master mix (New England BioLabs). Sequences were verified by Sanger DNA sequencing [Genomics Shared Resource, The Ohio State University Comprehensive Cancer Center (GSR OSUCCC)]. Recombinant proteins were purified by immobilized metal affinity chromatography (IMAC) as previously described30 using HisPur cobalt resin (Thermo Scientific). Before elution, proteins were subjected to on-column cleavage using TEV protease at a 1:20 mole ratio to 6xHis-tagged protein (estimated from resin binding capacity) overnight at 4°C. Purified proteins were dialyzed against ATP-free F-buffer, flash-frozen in liquid nitrogen, and stored at −80°C.

His-tagged ADF was expressed in BL21(DE3)-pLysS E. coli (Agilent Technologies) by induction with IPTG overnight at 15°C and purified using HisPur cobalt resin (Thermo Scientific) as described previously for human cofilins50. The 6xHis-tag was removed by TEV cleavage as described above, and the purified ADF was dialyzed against ADF buffer (10 mM HEPES, pH 7.0, 50 mM KCl, 2 mM MgCl2, 0.5 mM EGTA, 2 mM DTT), flash-frozen in liquid nitrogen and stored at −80 °C.

His-tagged mouse capping protein (CapZ heterodimer construct, a gift from Dr. J. Cooper) was purified from BL21(DE3)-pLysS E. coli (Agilent Technologies) as previously described30,51 using HisPur Cobalt resin (Thermo Scientific), and separated from high-molecular weight contaminants by size-exclusion chromatography using a Sephacryl S-200 HR column (Cytiva/GE Healthcare). The purified CapZ was flash-frozen in liquid N2 and stored at −80 °C in a buffer containing 20 mM Tris-HCl, pH 8.0, 80 mM KCl, 10 mM DTT, and 20% glycerol.

Labeling proteins with fluorescent probes

G-actin, present at ~50 μM was labelled with a 1.2 molar excess of either Alexa Fluor 488-maleimide, or Alexa Fluor 647-maleimide (both from Thermo Fisher) in G-buffer devoid of reducing agent overnight at 4°C in dark tubes, with their headspace filled with nitrogen gas. The labeled actin was then polymerized by the addition of MgCl2 and KCl to final concentrations of 1 and 50 mM respectively, for 1 h, followed by centrifugation at 300,000g for 30 min at 4°C in a TLA100.3 rotor using an Optima MAX-TL Ultracentrifuge (Beckman Coulter). The pellet was homogenized in G-buffer and depolymerized by three rounds of dialysis against G-buffer.

Pyrene-labeled actin was prepared by addition of 3-fold molar excess of N-(1-pyrene)iodoacetamide (Thermo Fisher) to 1 mg/mL F-actin in F-buffer devoid of reducing agent overnight at 4°C with mixing, in a dark tube with the headspace filled with nitrogen gas. Pyrenyl-F-actin was pelleted at 100,000g in a Ti-70 rotor in an Optima XPN 90 Ultracentrifuge (Beckman Coulter) for 90 min at 4°C followed by three rounds of dialysis of the resulting pellet against G-buffer41. All labeled actins were further purified by size-exclusion chromatography on a Superdex 200 Increase 10/300 GL column (GE Healthcare).

SipAC constructs were labeled with fluorescein maleimide (FM) or Alexa-Fluor 647 maleimide (both form Thermo Fisher Scientific) in SipAC buffer devoid of reducing agent overnight at 4°C as previously described for other proteins41.

Cryo-EM reconstruction

Sample preparation: G-actin was purified from rabbit skeletal muscle. G-actin was stored in G-buffer. Before the experiment, actin was converted to Mg2+-ATP G-actin by adding 0.4 mM EGTA and 0.1 mM MgCl2. To prepare F-actin/SipAC complex, 5 μM of G-actin was polymerized in G-actin buffer supplemented with 2 mM MgCl2 and 50 mM KCl for 24 hours at 4°C. SipAC in 25 mM Tris-HCl, pH 7.9 and 2 mM DTT was added at 5-fold molar excess to actin. 3-μL sample of F-actin/SipAC was applied on discharged lacey carbon grids, and plunge-frozen in liquid ethane using Leica EM GP plunge freezer. Movies were collected on Titan Krios at 300 keV equipped with Gatan K3 direct electron detector. Sampling was 1.08 Å per pixel, total defocus −2.4 to 1.4 μm, with a total dose of around 48 e2. Image processing was done in cryoSPARC52. Motion- and CTF-corrected images were manually curated for ice thickness and contrast transfer function (CTF) resolution, particles were extracted using 384 box size, followed by a round of 2D classification. To speed up data processing, initial processing was done on a smaller dataset of 169,910 particles (Figure S1). During 3D alignment of particles, a helical symmetry (rise: 27 Å, twist: −167°) was imposed. The first round of 3D classification into 2 classes was done with a bare actin filament and a SipAC-bound filament as the initial references. Based on visual inspection of the obtained volumes, a volume made from 90,134 particles showing higher occupancy for SipAC was subjected to 3D variability analysis (3DVA). 1,548,993 particles from a different larger set (384 box size) were then classified into 4 classes based on the volumes obtained from 3DVA. Each class was visually inspected, and a class composed of 349,272 particles was refined using a 112.075 Å rise and −306.344° twist. It was possible to model the actin filament and SipA molecules at 1:2 ratio without steric clashes into the reconstructed volume, supporting the use of these helical parameters. At this step the GSFSC resolution was 5.1 Å. We decided to use all 1,548,993 particles for the reconstruction to improve the resolution. During 3D alignment of 1,548,993 particles, a helical symmetry (rise: 27 Å, twist: −167°) was imposed to get initial alignments. Next, the position and orientation of volumes and particles were adjusted with helical parameters 112.075 Å rise and −306.344° twist and one of the volumes from 3DVA using “Volume alignment tool” in cryoSPARC. Then, non-uniform refinement on 1,548,993 particles was performed, giving a reconstruction of a SipA-decorated actin filament at ~3.2 Å resolution (Figure S1). Cryo-EM and refinement statistics of the SipAC/F-actin reconstruction are presented in Table S5.

SipA crystal structure (PDBID: 1Q5Z) and F-actin cryo-EM model (PDBID: 8D14) were used to build a model of SipAC-decorated F-actin using COOT53 and ChimeraX54. Since the 1Q5Z model contains residues 513–657, the missing residues of the C-terminal tail of SipAC (658–684) were manually built in COOT based on the reconstructed volume. The model was visually inspected and refined in Phenix. Figures were generated using ChimeraX. Mapping of interactions between SipA and F-actin was performed by PBDePISA server55. Amino acid residues in SipA model were counted as in the UniProt ID: P0CL52; amino acid sequence for actin model corresponds to UniProt ID: P68135, but in our model the residues were counted using the third aspartic acid as the first residue.

Analysis of actin’s His73 conformational change upon binding of SipAC

Cryo-EM reconstructions of human, rabbit, mouse, chicken, or yeast actin naked or in complex with actin-binding proteins at resolutions better than 3.5 Å were taken for comparison. Models were aligned based on the region between 68th and 93rd amino acid. The list of PDB IDs used for the alignment: 5OOF, 6C1D, 6DJM, 6DJN, 6FHL, 6KLL, 6KLN, 6T1Y, 6T23, 6UPV, 6UPW, 6VAO, 7AHN, 7K20, 7K21, 7P1G, 7PLT, 7PLU, 7PLY, 7PLZ, 7PM3, 7PM5, 7PM6, 7PMD, 7PME, 7PMF, 7PMG, 7PMH, 7PMI, 7PMJ, 7PML, 7R8V, 7R91, 7R94, 7UDT, 8A2R, 8A2S, 8A2T, 8A2U, 8A2Y, 8A2Z, 8D13, 8D14 and 7VVY.

Co-sedimentation assays

Ca2+ in the nucleotide cleft of G-actin was switched to Mg2+ by incubating with 0.1 mM MgCl2 and 0.5 mM EGTA on ice for 5 min. Actin was polymerized by adding KCl, MgCl2, and HEPES (pH 7.0) to final concentrations equal to those of F-buffer, and incubating for 30 min at 25°C. Polymerized F-actin was then mixed to a final concentration of 2.5 μM and titrated with SipAC. Reactions were incubated overnight at 4°C, then at 25°C for 1 hour before spinning at 300,000 g for 30 min at 25 °C in a TLA100 rotor in an Optima MAX-TL ultracentrifuge (Beckman Coulter). Supernatants were separated from pellets, resolved on 12% SDS-PAGE, stained with Coomassie brilliant blue dye, and quantified using ImageJ56 as described previously41,49. The concentration of SipAC in the pellet was quantified by determining the fraction of SipAC pelleted and multiplying it by the known concentration of SipAC in the reaction, allowing for the determination of binding stoichiometry. Data are presented as the average of three technical replicates, error bars show standard deviation (SD) between replicates.

Equilibrium fluorescence binding assays

To measure the binding affinity of SipAC for F-actin, FM-SipAC was diluted to a final concentration of 1 nM and titrated with F-actin. To limit actin depolymerization prior to the addition of SipAC, F-actin was polymerized at 5 μM, and rapidly diluted to the desired concentration in the presence of FM-SipAC. For FM-SipAC-ΔArm2 and FM-SipAC-Core, F-actin was stabilized by incubating with 10 μM phalloidin for 30 min at 25°C. FM-SipAC-ΔArm2 and FM-SipAC-Core were present at final concentrations of 100 nM and titrated with phalloidin-stabilized F-actin. The final concentration of phalloidin in the reactions was kept at 10 μM to ensure that at least 95% of actin subunits were occupied by phalloidin under all conditions. This step was necessary to prevent depolymerization of F-actin when it was present below its critical concentration. The binding reactions were incubated overnight at 4°C, then at 25°C for 1 hour before measurement. Fluorescence anisotropy (FA) was recorded as previously described41 using an Infinite M1000 plate reader (Tecan) with λex = 470 nm and λem = 530 nm. The affinities of TRITC-phalloidin and SiR-actin were measured using 100 nM TRITC-phalloidin (Sigma) or 10 nM SiR-actin (Cytoskeleton Inc.) titrated with F-actin, and incubated overnight at 4°C followed by 1-hour at 25 °C the next day. Since the fluorescence intensity of TRITC-phalloidin was not changed substantially upon its binding to actin, FA was selected as a reliable reporter of the interaction (Figure S8A,B). In contrast, the fluorescence intensity of SiR-actin increased dramatically upon its interaction with F-actin, making it impossible to accurately measure FA in the free and bound states within the same experiment. (Figure S8C,D). Therefore, fluorescence intensity (FI) was selected as the preferred reporter for SiR-actin binding. For TRITC-phalloidin, FA was recorded at λex = 530 nm and λem = 578 nm, for SiR-actin, FI was recorded at λex = 635 nm and λem = 674 nm. To estimate the binding affinity of the labeled proteins to F-actin, the relative FA or FI changes were fit to the binding isotherm (Equation 1) using Origin 2023 v10.0 (OriginLab Corporation):

SiSminSmaxSmin=P+x+Kd(P+x+Kd)24Px2P (Equation 1),

where Si is the signal (FA for FM/TRITC-labeled components or FI for SiR-actin) for a particular data point, Smin is the minimum signal recorded in that replicate, Smax is the maximum signal recorded in the replicate, P is the concentration of labeled binding protein, x is the concentration of actin, and Kd is the dissociation constant.

To determine the binding affinity of unlabeled protein for F-actin, we set up a competition assay as described previously41. Briefly, labeled components were incubated with F-actin for 30 min, before being incubated with unlabeled proteins of varying concentrations. The mixture was incubated overnight at 4°C, followed by 1 hour at 25°C. FA or FI signals were measured as above. The dissociation constant of the unlabeled protein was estimated by Equation 2:

SiSminSmaxSmin=Kd2Kd12Kd2LKd1x+Kd1L+Kd22Kd12+2Kd2Kd12x+2Kd2Kd12L+Kd12x22Kd12xL+Kd12L22(Kd2Kd1Kd2LKd1x+Kd12+Kd1L) (Equation 2),

where Kd1 is the Kd of the labeled component for actin, Kd2 is the Kd of the unlabeled component for actin, L is the actin concentration in the experiment, which is kept constant throughout the titration but is specific to each experiment, and x is the concentration of the unlabeled binding partner, which is titrated to the reaction mixture containing the labeled component and actin. The concentrations of actin and labeled protein used in each experiment are given in the Table S6. Data are presented as the average of three technical replicates, error bars show SD between replicates.

F-actin depolymerization assays

Pyrenyl-actin depolymerization assays were performed as described30. Briefly, 10% pyrene-labeled actin was polymerized as described for the co-sedimentation assay, supplemented with 0.1 μM CapZ and desired concentrations of either phalloidin, SipAC, or SipAC-ΔArm2, and incubated for 30 min at 25°C. The mixtures were transferred to a 384 well plate (Corning) in 20 μL aliquots. Depolymerization was initiated by the simultaneous addition of latrunculin B (LatB) to 4 μM and ADF to 0.25 μM using a multichannel pipet. The plate was immediately placed in an Infinite M1000 plate reader (Tecan) and the fluorescence intensity of pyrene was measured with λex = 365 nm and λem = 407 nm. The fluorescence data for each condition were normalized and corrected for photobleaching, using a sample of 10% pyrenyl-actin in the absence of CapZ, ADF, LatB, and toxin as a photobleaching control. Depolymerization curves were fit to single exponentials, and the decay rates were plotted against SipAC construct concentrations and fitted with a double exponential equation using Origin 2023 v10.0 (OriginLab Corporation) (Figure 6E). In addition, the initial decay rates were evaluated by fitting the first 3,000 s of depolymerization curves to a linear equation. The resulting slopes were plotted against SipAC concentration and fitted to a double exponential equation (Figure 6F). Data are presented as the average of at least three technical replicates, error bars show SD of the mean.

Cell culture, transient transfections, and microscopy

SipA constructs were cloned into mammalian expression vectors using NEBuilder assembly (New England Biolabs). SipA full-length (a.a. 1–685), SipA-NT (1–282), SipA-ΔNT (283–685), SipAC (425–685), SipAC-ΔArm1 (496–685), SipAC-ΔArm2 (425–658), SipAC-Core (512–659), and SipAC-tandem Core (a.a. 512–664 and a.a.512–659 separated by a linker PAYESGSSASG) were cloned into dCMV-EGFP, a plasmid with a defective CMV promoter optimized for low levels of fluorescent protein expression57, as reported previously32. Two SipAC-Arm2 (a.a. 659–684) constructs were created: 1) in-frame with C-terminal mEmerald-tag cloned into pcDNA3 and 2) with N-terminal TagRFPT cloned into TagRFPT-C1. pmCherry-F-tractin was a gift from Tobias Meyer (Addgene #155218; RRID: Addgene_155218)58. pEGFP-F-tractin was a gift from Dyche Mullins (Addgene #58473; RRID: Addgene_58473)59.

Human U2OS cells maintained at 37 °C with 5% CO2 in a humidified incubator in DMEM supplemented with 10% FBS, L-glutamine, and penicillin-streptomycin were co-transfected with F-tractin and various SipA constructs using Lipofectamine 3000 (Thermo Fisher Scientific). Whole-cell Z-stack images of transiently transfected cells were collected using Nikon AX confocal microscope system; maximum intensity projection images were generated using ImageJ software.

Differential scanning fluorimetry

The effects of phalloidin and SipAC constructs on the thermal stability of F-actin were measured using a CFX Connect Real-Time PCR system (Bio-Rad Laboratories) using Bio-Rad Manager v.3.1 software as previously described60. Reactions were carried out in F-buffer supplemented with SYPRO Orange dye (1x final concentration; Invitrogen). 1 μM actin was equilibrated with a range of toxin concentrations and incubated overnight at 4°C before measurement. Melting temperatures (Tm) were determined by calculating the maximum of the first derivative (dF/dT) of the fluorescence traces. Tms of actin were plotted against toxin concentrations using Origin 2023 v.10.0. These data are presented as the average of at least three technical replicates, error bars show SD of the mean.

F-actin severing assays

F-actin severing by ADF was assessed by TIRF microscopy in chambers made using 22 × 40 mm coverslips and 25 × 75 mm microscope slides (Fisher Scientific), adhered together using strips of double-sided tape. 1 μM Alexa-488-labeled (33%) actin was polymerized in F-buffer containing 50 mM KCl at 25°C for 30 min, then incubated overnight at 4°C to produce aged ADP-enriched actin. SipAC was added to the pre-polymerized actin to a final concentration of 5 or 50 nM and incubated overnight at 4°C. TIRF chambers were blocked by bovine serum albumin (BSA) by 2 consequent washes with 10 μL of high-salt BSA (HS-BSA) solution (1% BSA, 40 mM Tris-HCl, pH 7.5, 480 mM NaCl) followed by two 10-μL washes with low-salt-BSA (LS-BSA) solution (1% BSA, 40 mM Tris-HCl, pH 7.5, 120 mM KCl) and incubated for 5 min41. Using cut pipet tips to minimize sheering, filaments were diluted to 0.1 μM in TIRF buffer [10 mM imidazole, pH 7.0, 0.2 mM EGTA, 50 mM KCl, 10 mM ascorbic acid, 2.5 mM protocatechuate-3,4-dioxygenase (PCD), 0.1 μM protocatechuic acid (PCA) purified as described61, 100 mM DTT, 0.2 mM ATP, 0.1% BSA] and applied to the chamber. Images were collected with a Nikon Eclipse Ti-E microscope equipped with a TIRF illumination module (with a 15-mW laser), a Nikon CFI Plan Apochromat λ 100× oil objective (NA: 1.45), a perfect focus system (Nikon Instruments), and an iXon Ultra 897 EMCCD camera (Andor Technology). One pixel was equivalent to 160 × 160 nm. After the first 10 frames, 250 nM ADF with 37.5 nM CapZ in TIRF buffer (to prevent reannealing of severed filaments) or CapZ alone as a control were applied to the chamber and images were captured for additional 10 minutes. Using an automated stage, images were captured every 20 s in three separate locations per experiment and in three independent experiments (i.e., nine fields per experimental condition). The time-lapse images were analyzed using ImageJ software by counting severing events of 10 randomly selected filaments in each field of view. The means of cumulative severing events per μm per frame, standard error (SE) and SD of the mean were calculated from nine fields (n = 9) for each experimental condition. Severing was reported as the number of severing events per μm of filament length; error bars represent SE of the mean. For statistical analysis of cumulative severing events per μm of filament length at the endpoint of the experiment (t = 480 s), one-way analysis of variance (ANOVA) followed by Turkey’s post-test was performed using Origin 2023 v10.0 with the n value taken as the number of TIRF chamber locations analyzed (n = 9) (Figure S5).

Persistence length analysis

For persistence length measurements, the coverslips and microscope slides were cleaned as described62. Coverslips were then dried with nitrogen and layered with 200 μL of 2 mg/mL methoxy-poly (ethylene glycol)-silane (Laysan Bio Inc.) in 80% ethanol. The coverslips were placed in a covered metal dish with their treated sides up and incubated in an oven at 70°C overnight. The coverslips were stored under nitrogen atmosphere in 50 mL conical tubes wrapped in parafilm at −20°C. TIRF chambers were assembled from the treated coverslips and cleaned slides immediately prior to each experiment. To prepare freshly polymerized actin, Ca2+ in the nucleotide cleft of Alexa-488-labeled G-actin (3 μM; 33% labeled) was switched to Mg2+ by adding 0.1 mM MgCl2 and 0.5 mM EGTA and incubating for 2 min. Actin was then polymerized in TIRF buffer either alone or in the presence of saturating concentrations of SipAC (1.5 μM) or SipAC-ΔArm2 (3 μM). To evaluate the effects of SipAC on aged, ADP-enriched actin filaments, we prepared ADP-actin filaments as previously described63,64. Briefly, Alexa-488-actin (25 μM; 33% labeled) was polymerized for 30 min at 25°C in F-buffer, any remaining ATP was then hydrolyzed with hexokinase (Sigma Aldrich) in the presence of dextrose and Mg2+, by incubating for 30 min at 25°C, and continuing incubation on ice overnight to yield ADP-actin. ADP-BeF3 actin was prepared by supplementing ADP-actin with 5 mM NaF and 0.1 mM BeSO4 and incubating for at least 1 hour at 25°C. For phalloidin-stabilized ADP filaments, Alexa-488-ADP-actin (2 μM total; 33% labeled) was incubated with 2.1 μM phalloidin for 1 hour at 25°C and diluted to a final concentration of 0.1 μM actin immediately prior to the experiment. For SipAC-decorated ADP-actin filaments, Alexa-488 ADP-actin filaments (24 μM total; 33% labeled) were incubated with varying concentrations of SipAC for 3 hours at 25°C. The samples were diluted to a final concentration of 0.1 μM actin as above.

Filaments were observed using a Nikon Eclipse Ti-E microscope equipped with a perfect focus system, a TIRF illumination module (with a 15-mW laser), a Nikon CFI Plan Apochromat λ 100× oil objective (NA: 1.45), and a DS-QiMc camera (Nikon). One pixel was equivalent to 65 × 65 nm. Images were captured every 20 s for ~20 min in three locations in the TIRF chamber per experiment using an automated stage.

Filament contours (“snakes”) were generated using Jfilament65 from TIRF time-lapse image files. The resulting snake files were split into individual .dat files. These individual files were then analyzed using the “persistence length analyzer” MatLab script66 that determines the average persistence length and SD based on the cumulative curvature distributions of the data. The bootstrapping function was used with an m range of 1 to 40, bin size 75 to 110 over 50 iterations. Each analysis used at least 300 .dat files, generated from at least 30 individual actin filaments tracked for 10 consecutive frames. Only filaments no shorter than 10 μm were considered for the analysis.

Stopped-flow binding and dissociation assays

Time courses of FM-labeled SipAC constructs binding to or dissociating from actin filaments were recorded, and association and dissociation rates were determined by the change in fluorescence anisotropy signal, detected by an SX-20 LED stopped-flow spectrometer (Applied Photophysics) at 25 °C. Excitation of the sample at 470 nm was accomplished by an LED element (Applied Photophysics), and changes in fluorescence anisotropy were measured using two identical 515 nm long-pass colored glass filters (Newport Corporation). For association rates, the reaction was initiated by mixing equal volumes of 100 nM FM-SipAC constructs with equal volumes of F-actin at a range of concentrations in F-buffer. For dissociation rate measurements, an equilibrated mixture of FM-SipAC construct and F-actin was mixed with at least 10-fold excess of unlabeled SipAC construct in F-buffer. The dead-time of the instrument is 1 ms.

Time courses from the association experiments were combined, averaged, and smoothed using Pro-Data SX and Pro-Data viewer (Applied Photophysics) and fit to a single exponential. The resulting kobs values were plotted against actin concentration in Origin 2023 v10.0 and fit to a linear line, the slope of which yielded the sought kon values, and the y-intercept was a rough estimate of koff. All kobs values are the result of at least 10 association time-course replicates; error bars represent curve fit error. All kon values are reported with their curve fit errors. koff values were then measured by observing the dissociation of the fluorescently labeled constructs from F-actin upon their competition with the excess of unlabeled proteins. The koff values for SipAC-Core and SipAC-ΔArm2 were determined by averaging curves from at least ten replicates for two different concentrations of the unlabeled binding partner (at least 60-fold molar excess over the labeled protein and 10-fold molar excess over the concentration of actin). Due to the dual binding mode of SipAC, unusually high concentrations of unlabeled SipAC (i.e., 800 and 1000-fold molar excess) were required to effectively displace the labeled protein from F-actin. The dissociation curves of four repetitions at the 1000-fold molar excess of unlabeled SipAC were used (Figure 4B). The dissociation time courses were averaged, smoothed, fit to a single exponential, and reported together with the curve fit errors derived from the plots produced using the stopped-flow instrument software packages Pro-Data SX and Pro-Data viewer. The experimental koff values were added to the experimental association graphs to define the intersection of the linear fits of kobs with the y -axis. The resulting plots maintained the linear dependence on actin concentration and produced the corrected kon values reported in Figure 4A.

Single-molecule TIRFM-based dissociation assays

To eliminate the competition effect on the dissociation of SipAC from F-actin, we visualized the spontaneous drop in the number of Alexa-647 labeled SipAC spots associated with Alexa-488 labeled actin filaments in TIRF microscopy (Figure 4D). TIRF chambers were prepared as described above, except that cleaned and dry coverslips were layered with 200 μL of 2 mg/mL methoxy-poly (ethylene glycol)-silane (Laysan Bio Inc.) and 2 μg/mL biotin-PEG-silane (MW 3,400 g/mol, Layson Bio Inc.) in 80% ethanol. SipAC buffer containing 0.01 mg/mL streptavidin and 1% BSA was flowed into the assembled TIRF chamber and incubated for 1 minute, followed by washing with HS-BSA and LS-BSA solutions. To attach F-actin to the substrate and simultaneously stabilize it, SipAC labeled with EZ-Link maleimide-PEG2-biotin (Thermo Fisher Scientific) was flushed into the chamber at a concentration of 1 μM, and incubated for 5 min, followed by the replacement of the unbound protein with 15 μL of 1x TIRF buffer. Alexa-488 actin (10% to total actin) was polymerized in the TIRF chamber as described in the persistence length measurement section of the methods. The presence of biotinylated SipAC anchored the Alexa-488 actin filaments to the glass surface and prevented their depolymerization. Alexa-647-labeled SipAC at a concentration of 0.1 nM in TIRF buffer was then added to the TIRF chamber and allowed to decorate actin filaments to the level of individual, clearly distinguishable spots. Unbound Alexa-647-labeled SipAC was washed away by 3 consecutive additions of 15 μL TIRF buffer. The chamber was then sealed with a melted 1:1:1 mixture of Vaseline, lanolin and paraffin (VALAP) to prevent evaporation of the experimental mixture.

To distinguish between SipAC dissociation and photobleaching of the fluorophore (Alexa-647), we monitored drop in fluorescence of Alexa-647-actin (0.5%) copolymerized with Alexa 488-actin (10%) and unlabeled actin (89.5%), stabilized by phalloidin (1.25μM) and biotinylated SipAC, which was also used to attach the filaments to the glass surface as described above. Since filaments did not visibly shorten during the experiment duration, we assumed that disappearance of the Alexa-647-actin spots was due to the fluorophore photobleaching. The disappearance of Alexa-647 SipAC or Alexa-647-actin spots were quantified using the TrackMate plugin67 in ImageJ. Briefly, only the spots that were present in the first frame of the TIRF movie were identified and tracked until they disappeared. Rare new spots that came into the frame (likely representing the re-binding of dissociated Alexa-647 SipAC) were not considered, nor were spots that left the field of view due to small shifts in camera position. Alexa-647 SipAC dissociation data were corrected for photobleaching and plotted as average of four independent experiments. Error bars are reported as SD of the mean.

Actin polymerization assays

For polymerization assays, monomeric actin was separated from oligomeric species by passing it through a HiPrep 26/60 Sephacryl S-200 HR size-exclusion column (GE Healthcare) equilibrated in G-buffer. Nuclei-free G-actin from the trailing half of the chromatographic peak was used in the subsequent assays. Actin polymerization was initiated by the addition of 20x EnzChek phosphate assay (Thermo Fisher Scientific) buffer to a final concentration of 1x (50 mM Tris-HCl, pH 7.5, 1 mM MgCl2, 0.1 mM NaN3) in a 3 mm cuvette (Starna Cells, Inc). The final concentration of actin was 10 μM. When desired, SipAC or SipAC-Δarm2 (10 μM final concentration) were added to actin together with the phosphate assay buffer. Polymerization was monitored by changes in light scattering at 90° to the incident light using a PTI QuantaMaster 400 spectrofluorometer (Horiba) at 25 °C. The excitation and emission wavelengths were set to 350 nm with 1.5 nm instrument slit size and ~2 mm house-made carboard slits installed at the excitation and emission sides of the sample chamber. Prior to the experiment, all solutions were degassed for 1 hour under vacuum. The intensity signal was normalized to the maximum of each condition before averaging, error bars represent SD of the mean. Each curve is the average of at least two independent experiments.

Pi release assays

Inorganic phosphate (Pi) release from polymerizing F-actin was performed using an EnzChek phosphate assay kit (Thermo Fisher Scientific) according to the manufacturer’s protocol and under conditions identical to those described above for actin polymerization. Polymerization was initiated by adding Sephacryl S-200-purified G-actin to a “pre-reaction” solution in the plate containing the relevant SipAC construct, 2-amino-6-mercapto-7-methyl-purine riboside (MESG) substrate, phosphate assay kit reaction buffer, and purine nucleoside phosphorylase (PNP). After addition of actin, the final volume of the reaction in the plate was 200 μL, with final concentrations of 10 μM actin, 10 μM SipAC construct, 200 μM MESG substrate, 1 unit/mL PNP, 50 mM Tris-HCl, pH 7.5, 1 mM MgCl2, 0.1 mM NaN3. Reactions were assembled in a 96-well UV-transparent flat-bottom plate (Thermo Fisher Scientific), and reaction progress was monitored by observing absorbance at 360 nm using an Infinite M1000 plate reader (Tecan) with temperature held constant at 25°C. To obtain a strong and reliable signal, it was essential to use 10 μM actin in a 200 μL reaction volume. Measurements were taken every 30 s for 10,000 s. Absorbance traces for actin alone and actin with SipAC-Δarm2 showed a decrease in signal after reaching the plateau, which we interpret as spontaneous degradation of the MESG-Pi product68. For clarity, that portion of the curve was removed. Each curve is the result of at least three technical replicates over at least two independent experiments. Error bars are reported as SD of the mean.

Comparison of Pi release and polymerization rates

Since polymerization curves were shorter than Pi release curves, we extrapolated our data by fitting them to the Hill equation (Equation 3) and subtracted the Pi release fits from their respective polymerization counterparts.

SiSminSmaxSmin=tnK+tn (Equation 3),

where t is the time, n is the Hill coefficient, and K is a constant. This manipulation produced a plot which shows the fraction of filamentous actin in the ATP or ADP-Pi state for any given time point during the experiment, as shown in Figure 8B.

Quantification and Statistical analysis

Graphical data were plotted and analyzed using Origin 2023 v10.0 and Microsoft Excel for Microsoft 365 MSO Version 2307 (Microsoft Corporation). All graph data are presented as the mean ± standard deviation (SD) or standard error (SE) of the mean as indicated in the corresponding method sections. The number of repetitions (n) is indicated in the method section for each technique. For statistical analysis of cumulative severing events of actin filaments, one-way analysis of variance (ANOVA) followed by Turkey’s post-test was performed using Origin 2023 v10.0 with the n value taken as the number of TIRF chamber locations analyzed (n = 9). For statistical analysis of persistence length measurements, one-way ANOVA followed by Turkey’s post-test was applied using a browser-based calculator (https://statpages.info/anova1sm.html) with the n value taken as the number of filaments measured for each experiment (n=30 – 45).

Supplementary Material

1

Supplemental Video S1 Legend

Video S1. SipAC protects F-actin against severing by ADF, related to Figures 6G,H and S5. F-actin (100 nM of 33%-Alexa-488 labeled F-actin) severing was observed by TIRF microscopy. Images of actin filaments were captured for 8 frames before applying indicated proteins: left panel, 37.5 nM CapZ was added to bare actin; middle panel, 37.5 nM CapZ and 250 nM ADF were added to bare actin; right panel, 37.5 nM CapZ and 250 nM ADF were added to 100 nM F-actin pre-decorated with 5 nM SipAC. CapZ was added to actin filaments in all three experiments to cap barbed ends to prevent reannealing of severed filaments. In the presence of SipAC, very short filaments appear with time that are not the result of severing events within the analyzed frame. They likely represent filaments severed elsewhere in the chamber, which accumulate as their depolymerization is strongly inhibited by SipAC.

Download video file (1.6MB, avi)
2

Key resources table

REAGENT or RESOURCE SOURCE IDENTIFIER
Bacterial and virus strains
E. coli BL21(DE3)-pLysS Agilent Technologies Cat. #200132
Biological samples
Rabbit skeletal muscle acetone powder (Oryctolagus cuniculus) Pel-Freeze Biologicals Cat. #41995-2
Chemicals, peptides, and recombinant proteins
Alexa Fluor 488-maleimide Thermo Fisher Cat. #A10254
Alexa Fluor 647 maleimide Thermo Fisher Scientific Cat. #A20347
N-(1-pyrene)iodoacetamide Fisher Scientific Cat. #11599256
Fluorescein maleimide Thermo Scientific Cat. #62245
Phalloidin Sigma Cat. #P2141-1MG
TRITC-phalloidin Sigma Cat. #P1951
SiR-actin Cytoskeleton Inc. Cat. #CY-SC001
SYPRO Orange Invitrogen Cat. #S6650
Rabbit skeletal muscle α-actin This work NA
Capping protein (CapZ) Dong et al.30 NA
SipAC (a.a. 425 - 685) This work NA
SipAC-ΔArm2 (a.a. 425 - 685) This work NA
SipAC-Core (a.a 512 - 685) This work NA
Critical commercial assays
NEBuilder HiFi DNA assembly master mix New England BioLabs Cat. #E2621S
EnzChek phosphate assay kit Thermo Fisher Scientific Cat. #E6646
Deposited data
SipAC/F-actin This work PDB ID: 8UEE; EMDB ID: EMD-42161
Experimental models: Cell lines
Human U2OS cells ATCC RRID: CVCL_0042
Oligonucleotides
For complete list refer to Table S4 This work NA
Recombinant DNA
SipAC cloned into pGEX Lilic et al.6 NA
SipAC-ΔArm2 cloned into pColdl-TEV This work NA
SipAC-Core cloned into pColdI-TEV This work NA
6xHis-ADF cloned into pColdI-TEV Kraus et al.50 NA
α1 and β2 CapZ subunits in pRSFDuet Johnson et al.51 NA
SipA full length cloned into dCMV-EGFP This work NA
SipA-NT cloned into dCMV-EGFP This work NA
SipA-ΔNT cloned into dCMV-EGFP This work NA
SipAC cloned into dCMV-EGFP This work NA
SipAC-ΔArml cloned into dCMV-EGFP This work NA
SipAC-Core cloned into dCMV-EGFP This work NA
SipAC-tandem Core cloned into dCMV-EGFP This work NA
SipAC-Arm2 with C-terminal mEmerald tag cloned into pcDNA3 This work NA
SipAC-Arm2 with N-terminal TagRFPT cloned into TagRFPT-C1 This work NA
pmCherry-F-tractin Bisaria et al.58 RRID: Addgene_155218
pEGFP-F-tractin Belin et al.59 RRID: Addgene_58473
Software and algorithms
cryoSPARC Punjani et al.52 https://crvosparc.com
COOT Emsley et al.53 https://www.ccpem.ac.uk/
ChimeraX Pettersen et al.54 https://www.cal.ucsf.edu/chimerax/
ImageJ Schindelin et al.56 https://imagej.net/
Origin 2023 v10.0 OriginLab Corporation https://www.orisinlab.com/
Bio-Rad Manager v.3.1 Bio-Rad https://www.bio-rad.com/en-us/product/previous-qpcr-software-releases?ID=OO2BB34VY
Jfilament Smith et al.65 https://www.lehieh.edu/~div206/ifilament/
Persistence length analyzer Wisanpitayakorn et al.66 https://github.com/tuzellab
TrackMate 7 Ershov et al.67 https://imagej.net/plugins/trackmate/
Pro-Data SX Applied Photophysics https://www.photophysics.com/service-support/upgrades/stopped-flow-upgrades/
Pro-Data viewer Applied Photophysics https://www.photophysics.com/service-support/upgrades/stopped-flow-upgrades/

Highlights:

  • A 3.2 Å resolution cryo-EM structure of SipAC bound to F-actin is reported

  • SipAC binds to F-actin with ~100 pM affinity via its Core and Arm2 domains

  • Arm2 incorporation between actin strands increases filament stiffness

  • The increased stiffness is a likely reason for cooperative filament stabilization

Acknowledgments

We would like to thank Harper Smith for help with the persistence length analysis and Kotaro Nakanishi for providing access to the Nikon AX confocal microscope. This work was supported by NIH R35GM122510 (to E.H.E.) and NIH R01GM114666 and R01GM145813 (to D.S.K.). Transmission electron micrographs were recorded at the University of Virginia Molecular Electron Microscopy Core facility (RRID: SCR_019031), which is supported in part by the School of Medicine. In addition, the Titan Krios (SIG S10-RR025067), Falcon II/3EC direct detector (SIG S10-OD018149), and K3/GIF (U24-GM116790) were purchased in part or in full with the designated NIH grants.

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

Declaration of Interests

The authors declare that they have no conflict of interest.

References:

  • 1.World Health, O. (2015). WHO estimates of the global burden of foodborne diseases: foodborne disease burden epidemiology reference group 2007–2015 (World Health Organization).
  • 2.Coburn B, Sekirov I, and Finlay BB (2007). Type III secretion systems and disease. Clin.Microbiol.Rev 20, 535–549. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Raffatellu M, Wilson RP, Chessa D, Andrews-Polymenis H, Tran QT, Lawhon S, Khare S, Adams LG, and Baumler AJ (2005). SipA, SopA, SopB, SopD, and SopE2 contribute to Salmonella enterica serotype typhimurium invasion of epithelial cells. Infect Immun 73, 146–154. 10.1128/IAI.73.1.146-154.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Jepson MA, Kenny B, and Leard AD (2001). Role of sipA in the early stages of Salmonella typhimurium entry into epithelial cells. Cell Microbiol 3, 417–426. 10.1046/j.1462-5822.2001.00124.x. [DOI] [PubMed] [Google Scholar]
  • 5.Fattinger SA, Bock D, Di Martino ML, Deuring S, Samperio Ventayol P, Ek V, Furter M, Kreibich S, Bosia F, Muller-Hauser AA, et al. (2020). Salmonella Typhimurium discreet-invasion of the murine gut absorptive epithelium. PLoS Pathog 16, e1008503. 10.1371/journal.ppat.1008503. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Lilic M, Galkin VE, Orlova A, VanLoock MS, Egelman EH, and Stebbins CE (2003). Salmonella SipA polymerizes actin by stapling filaments with nonglobular protein arms. Science 301, 1918–1921. [DOI] [PubMed] [Google Scholar]
  • 7.Lilic M, Vujanac M, and Stebbins CE (2006). A common structural motif in the binding of virulence factors to bacterial secretion chaperones. Mol Cell 21, 653–664. 10.1016/j.molcel.2006.01.026. [DOI] [PubMed] [Google Scholar]
  • 8.Schlumberger MC, Kappeli R, Wetter M, Muller AJ, Misselwitz B, Dilling S, Kremer M, and Hardt WD (2007). Two newly identified SipA domains (F1, F2) steer effector protein localization and contribute to Salmonella host cell manipulation. Mol Microbiol 65, 741–760. 10.1111/j.1365-2958.2007.05823.x. [DOI] [PubMed] [Google Scholar]
  • 9.Singh PK, Kapoor A, Lomash RM, Kumar K, Kamerkar SC, Pucadyil TJ, and Mukhopadhyay A (2018). Salmonella SipA mimics a cognate SNARE for host Syntaxin8 to promote fusion with early endosomes. J Cell Biol 217, 4199–4214. 10.1083/jcb.201802155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Wall DM, Nadeau WJ, Pazos MA, Shi HN, Galyov EE, and McCormick BA (2007). Identification of the Salmonella enterica serotype typhimurium SipA domain responsible for inducing neutrophil recruitment across the intestinal epithelium. Cell Microbiol 9, 2299–2313. 10.1111/j.1462-5822.2007.00960.x. [DOI] [PubMed] [Google Scholar]
  • 11.McIntosh A, Meikle LM, Ormsby MJ, McCormick BA, Christie JM, Brewer JM, Roberts M, and Wall DM (2017). SipA Activation of Caspase-3 Is a Decisive Mediator of Host Cell Survival at Early Stages of Salmonella enterica Serovar Typhimurium Infection. Infect Immun 85. 10.1128/IAI.00393-17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Srikanth CV, Wall DM, Maldonado-Contreras A, Shi H, Zhou D, Demma Z, Mumy KL, and McCormick BA (2010). Salmonella pathogenesis and processing of secreted effectors by caspase-3. Science 330, 390–393. 10.1126/science.1194598. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Zhou D, Mooseker MS, and Galan JE (1999). Role of the S. typhimurium actin-binding protein SipA in bacterial internalization. Science 283, 2092–2095. [DOI] [PubMed] [Google Scholar]
  • 14.McGhie EJ, Hayward RD, and Koronakis V (2004). Control of actin turnover by a salmonella invasion protein. Mol Cell 13, 497–510. 10.1016/s1097-2765(04)00053-x. [DOI] [PubMed] [Google Scholar]
  • 15.Svitkina T (2018). The Actin Cytoskeleton and Actin-Based Motility. Cold Spring Harb Perspect Biol 10. 10.1101/cshperspect.a018267. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Dominguez R, and Holmes KC (2011). Actin structure and function. Annu.Rev.Biophys 40, 169–186. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Rajan S, Kudryashov DS, and Reisler E (2023). Actin Bundles Dynamics and Architecture. Biomolecules 13. 10.3390/biom13030450. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Pollard TD, and Borisy GG (2003). Cellular motility driven by assembly and disassembly of actin filaments. Cell 112, 453–465. [DOI] [PubMed] [Google Scholar]
  • 19.Das S, Ge P, Oztug Durer ZA, Grintsevich EE, Zhou ZH, and Reisler E (2020). D-loop Dynamics and Near-Atomic-Resolution Cryo-EM Structure of Phalloidin-Bound F-Actin. Structure 28, 586–593 e583. 10.1016/j.str.2020.04.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Pospich S, Merino F, and Raunser S (2020). Structural Effects and Functional Implications of Phalloidin and Jasplakinolide Binding to Actin Filaments. Structure 28, 437–449 e435. 10.1016/j.str.2020.01.014. [DOI] [PubMed] [Google Scholar]
  • 21.Silacci P, Mazzolai L, Gauci C, Stergiopulos N, Yin HL, and Hayoz D (2004). Gelsolin superfamily proteins: key regulators of cellular functions. Cell Mol Life Sci 61, 2614–2623. 10.1007/s00018-004-4225-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Carlier MF, Laurent V, Santolini J, Melki R, Didry D, Xia GX, Hong Y, Chua NH, and Pantaloni D (1997). Actin depolymerizing factor (ADF/cofilin) enhances the rate of filament turnover: implication in actin-based motility. Journal of Cell Biology 136, 1307–1322. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Suarez C, Roland J, Boujemaa-Paterski R, Kang H, McCullough BR, Reymann AC, Guerin C, Martiel JL, De La Cruz EM, and Blanchoin L (2011). Cofilin tunes the nucleotide state of actin filaments and severs at bare and decorated segment boundaries. Curr.Biol 21, 862–868. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Galkin VE, Orlova A, VanLoock MS, Zhou D, Galan JE, and Egelman EH (2002). The bacterial protein SipA polymerizes G-actin and mimics muscle nebulin. Nat.Struct.Biol 9, 518–521. [DOI] [PubMed] [Google Scholar]
  • 25.Punjani A, and Fleet DJ (2021). 3D variability analysis: Resolving continuous flexibility and discrete heterogeneity from single particle cryo-EM. J Struct Biol 213, 107702. 10.1016/j.jsb.2021.107702. [DOI] [PubMed] [Google Scholar]
  • 26.Reynolds MJ, Hachicho C, Carl AG, Gong R, and Alushin GM (2022). Bending forces and nucleotide state jointly regulate F-actin structure. Nature 611, 380–386. 10.1038/s41586-022-05366-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Merino F, Pospich S, Funk J, Wagner T, Kullmer F, Arndt HD, Bieling P, and Raunser S (2018). Structural transitions of F-actin upon ATP hydrolysis at near-atomic resolution revealed by cryo-EM. Nat Struct Mol Biol 25, 528–537. 10.1038/s41594-018-0074-0. [DOI] [PubMed] [Google Scholar]
  • 28.Vauquelin G, and Charlton SJ (2013). Exploring avidity: understanding the potential gains in functional affinity and target residence time of bivalent and heterobivalent ligands. Br J Pharmacol 168, 1771–1785. 10.1111/bph.12106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.De La Cruz EM, and Pollard TD (1994). Transient kinetic analysis of rhodamine phalloidin binding to actin filaments. Biochemistry 33, 14387–14392. 10.1021/bi00252a003. [DOI] [PubMed] [Google Scholar]
  • 30.Dong S, Zheng W, Pinkerton N, Hansen J, Tikunova SB, Davis JP, Heissler SM, Kudryashova E, Egelman EH, and Kudryashov DS (2022). Photorhabdus luminescens TccC3 Toxin Targets the Dynamic Population of F-Actin and Impairs Cell Cortex Integrity. Int J Mol Sci 23. 10.3390/ijms23137026. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Heisler DB, Kudryashova E, Grinevich DO, Suarez C, Winkelman JD, Birukov KG, Kotha SR, Parinandi NL, Vavylonis D, Kovar DR, and Kudryashov DS (2015). ACTIN-DIRECTED TOXIN. ACD toxin-produced actin oligomers poison formin-controlled actin polymerization. Science 349, 535–539. 10.1126/science.aab4090. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Kudryashova E, Heisler DB, Williams B, Harker AJ, Shafer K, Quinlan ME, Kovar DR, Vavylonis D, and Kudryashov DS (2018). Actin Cross-Linking Toxin Is a Universal Inhibitor of Tandem-Organized and Oligomeric G-Actin Binding Proteins. Curr Biol 28, 1536–1547 e1539. 10.1016/j.cub.2018.03.065. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Funk J, Merino F, Schaks M, Rottner K, Raunser S, and Bieling P (2021). A barbed end interference mechanism reveals how capping protein promotes nucleation in branched actin networks. Nat Commun 12, 5329. 10.1038/s41467-021-25682-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.De La Cruz EM, and Pollard TD (1996). Kinetics and thermodynamics of phalloidin binding to actin filaments from three divergent species. Biochemistry 35, 14054–14061. 10.1021/bi961047t. [DOI] [PubMed] [Google Scholar]
  • 35.Nishimura M, Fujii T, Hiyoshi H, Makino F, Inoue H, Motooka D, Kodama T, Ohkubo T, Kobayashi Y, Nakamura S, et al. (2015). A repeat unit of Vibrio diarrheal T3S effector subverts cytoskeletal actin homeostasis via binding to interstrand region of actin filaments. Sci Rep 5, 10870. 10.1038/srep10870. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Wriggers W, and Schulten K (1999). Investigating a back door mechanism of actin phosphate release by steered molecular dynamics. Proteins 35, 262–273. [PubMed] [Google Scholar]
  • 37.Wilkinson AW, Diep J, Dai S, Liu S, Ooi YS, Song D, Li TM, Horton JR, Zhang X, Liu C, et al. (2019). SETD3 is an actin histidine methyltransferase that prevents primary dystocia. Nature 565, 372–376. 10.1038/s41586-018-0821-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Nyman T, Schuler H, Korenbaum E, Schutt CE, Karlsson R, and Lindberg U (2002). The role of MeH73 in actin polymerization and ATP hydrolysis. J Mol Biol 317, 577–589. 10.1006/jmbi.2002.5436. [DOI] [PubMed] [Google Scholar]
  • 39.Guo Q, Liao S, Kwiatkowski S, Tomaka W, Yu H, Wu G, Tu X, Min J, Drozak J, and Xu C (2019). Structural insights into SETD3-mediated histidine methylation on beta-actin. Elife 8. 10.7554/eLife.43676. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Kabsch W, Mannherz HG, Suck D, Pai EF, and Holmes KC (1990). Atomic structure of the actin:DNase I complex. Nature 347, 37–44. [DOI] [PubMed] [Google Scholar]
  • 41.Schwebach CL, Kudryashova E, Agrawal R, Zheng W, Egelman EH, and Kudryashov DS (2022). Allosteric regulation controls actin-bundling properties of human plastins. Nat Struct Mol Biol 29, 519–528. 10.1038/s41594-022-00771-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Galan JE, and Zhou D (2000). Striking a balance: modulation of the actin cytoskeleton by Salmonella. Proc.Natl.Acad.Sci.U.S.A 97, 8754–8761. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Zhou D, Mooseker MS, and Galan JE (1999). An invasion-associated Salmonella protein modulates the actin-bundling activity of plastin. Proc Natl Acad Sci U S A 96, 10176–10181. 10.1073/pnas.96.18.10176. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Schwebach CL, Kudryashova E, Zheng W, Orchard M, Smith H, Runyan LA, Egelman EH, and Kudryashov DS (2020). Osteogenesis imperfecta mutations in plastin 3 lead to impaired calcium regulation of actin bundling. Bone Res 8, 21. 10.1038/s41413-020-0095-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Mei L, Reynolds MJ, Garbett D, Gong R, Meyer T, and Alushin GM (2022). Structural mechanism for bidirectional actin cross-linking by T-plastin. Proc Natl Acad Sci U S A 119, e2205370119. 10.1073/pnas.2205370119. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Yuan B, Scholz J, Wald J, Thuenauer R, Hennell James R, Ellenberg I, Windhorst S, Faix J, and Marlovits TC (2023). Structural basis for subversion of host cell actin cytoskeleton during Salmonella infection. Sci Adv 9, eadj5777. 10.1126/sciadv.adj5777. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Uphoff CC, and Drexler HG (2014). Detection of Mycoplasma contamination in cell cultures. Curr Protoc Mol Biol 106, 28 24 21–28 24 14. 10.1002/0471142727.mb2804s106. [DOI] [PubMed] [Google Scholar]
  • 48.Pardee JD, and Spudich JA (1982). Purification of muscle actin. Methods Cell Biol 24, 271–289. 10.1016/s0091-679x(08)60661-5. [DOI] [PubMed] [Google Scholar]
  • 49.Schwebach CL, Agrawal R, Lindert S, Kudryashova E, and Kudryashov DS (2017). The Roles of Actin-Binding Domains 1 and 2 in the Calcium-Dependent Regulation of Actin Filament Bundling by Human Plastins. J Mol Biol 429, 2490–2508. 10.1016/j.jmb.2017.06.021. [DOI] [PubMed] [Google Scholar]
  • 50.Kraus J, Russell RW, Kudryashova E, Xu C, Katyal N, Perilla JR, Kudryashov DS, and Polenova T (2022). Magic angle spinning NMR structure of human cofilin-2 assembled on actin filaments reveals isoform-specific conformation and binding mode. Nat Commun 13, 2114. 10.1038/s41467-022-29595-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Johnson B, McConnell P, Kozlov AG, Mekel M, Lohman TM, Gross ML, Amarasinghe GK, and Cooper JA (2018). Allosteric Coupling of CARMIL and V-1 Binding to Capping Protein Revealed by Hydrogen-Deuterium Exchange. Cell Rep 23, 2795–2804. 10.1016/j.celrep.2018.04.096. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Punjani A, Rubinstein JL, Fleet DJ, and Brubaker MA (2017). cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat Methods 14, 290–296. 10.1038/nmeth.4169. [DOI] [PubMed] [Google Scholar]
  • 53.Emsley P, Lohkamp B, Scott WG, and Cowtan K (2010). Features and development of Coot. Acta crystallographica. Section D, Biological crystallography 66, 486–501. 10.1107/S0907444910007493. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Pettersen EF, Goddard TD, Huang CC, Meng EC, Couch GS, Croll TI, Morris JH, and Ferrin TE (2021). UCSF ChimeraX: Structure visualization for researchers, educators, and developers. Protein Sci 30, 70–82. 10.1002/pro.3943. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Krissinel E, and Henrick K (2007). Inference of macromolecular assemblies from crystalline state. J Mol Biol 372, 774–797. 10.1016/j.jmb.2007.05.022. [DOI] [PubMed] [Google Scholar]
  • 56.Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, Preibisch S, Rueden C, Saalfeld S, Schmid B, et al. (2012). Fiji: an open-source platform for biological-image analysis. Nat Methods 9, 676–682. 10.1038/nmeth.2019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Watanabe N (2012). Fluorescence single-molecule imaging of actin turnover and regulatory mechanisms. Methods Enzymol 505, 219–232. 10.1016/B978-0-12-388448-0.00020-6. [DOI] [PubMed] [Google Scholar]
  • 58.Bisaria A, Hayer A, Garbett D, Cohen D, and Meyer T (2020). Membrane-proximal F-actin restricts local membrane protrusions and directs cell migration. Science 368, 1205–1210. 10.1126/science.aay7794. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Belin BJ, Goins LM, and Mullins RD (2014). Comparative analysis of tools for live cell imaging of actin network architecture. Bioarchitecture 4, 189–202. 10.1080/19490992.2014.1047714. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Kudryashova E, Quintyn R, Seveau S, Lu W, Wysocki VH, and Kudryashov DS (2014). Human defensins facilitate local unfolding of thermodynamically unstable regions of bacterial protein toxins. Immunity 41, 709–721. 10.1016/j.immuni.2014.10.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Kudryashova E, Ankita, Ulrichs H, Shekhar S, and Kudryashov DS (2022). Pointed-end processive elongation of actin filaments by Vibrio effectors VopF and VopL. Sci Adv 8, eadc9239. 10.1126/sciadv.adc9239. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Chin SM, Jansen S, and Goode BL (2016). TIRF microscopy analysis of human Cof1, Cof2, and ADF effects on actin filament severing and turnover. J Mol Biol 428, 1604–1616. 10.1016/j.jmb.2016.03.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Pollard TD (1984). Polymerization of ADP-actin. J Cell Biol 99, 769–777. 10.1083/jcb.99.3.769. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Ge P, Durer ZA, Kudryashov D, Zhou ZH, and Reisler E (2014). Cryo-EM reveals different coronin binding modes for ADP- and ADP-BeFx actin filaments. Nat Struct Mol Biol 21, 1075–1081. 10.1038/nsmb.2907. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Smith MB, Li H, Shen T, Huang X, Yusuf E, and Vavylonis D (2010). Segmentation and tracking of cytoskeletal filaments using open active contours. Cytoskeleton (Hoboken) 67, 693–705. 10.1002/cm.20481. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Wisanpitayakorn P, Mickolajczyk KJ, Hancock WO, Vidali L, and Tuzel E (2022). Measurement of the persistence length of cytoskeletal filaments using curvature distributions. Biophys J 121, 1813–1822. 10.1016/j.bpj.2022.04.020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Ershov D, Phan MS, Pylvanainen JW, Rigaud SU, Le Blanc L, Charles-Orszag A, Conway JRW, Laine RF, Roy NH, Bonazzi D, et al. (2022). TrackMate 7: integrating state-of-the-art segmentation algorithms into tracking pipelines. Nat Methods 19, 829–832. 10.1038/s41592-022-01507-1. [DOI] [PubMed] [Google Scholar]
  • 68.Webb MR (1992). A continuous spectrophotometric assay for inorganic phosphate and for measuring phosphate release kinetics in biological systems. Proc Natl Acad Sci U S A 89, 4884–4887. 10.1073/pnas.89.11.4884. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

1

Supplemental Video S1 Legend

Video S1. SipAC protects F-actin against severing by ADF, related to Figures 6G,H and S5. F-actin (100 nM of 33%-Alexa-488 labeled F-actin) severing was observed by TIRF microscopy. Images of actin filaments were captured for 8 frames before applying indicated proteins: left panel, 37.5 nM CapZ was added to bare actin; middle panel, 37.5 nM CapZ and 250 nM ADF were added to bare actin; right panel, 37.5 nM CapZ and 250 nM ADF were added to 100 nM F-actin pre-decorated with 5 nM SipAC. CapZ was added to actin filaments in all three experiments to cap barbed ends to prevent reannealing of severed filaments. In the presence of SipAC, very short filaments appear with time that are not the result of severing events within the analyzed frame. They likely represent filaments severed elsewhere in the chamber, which accumulate as their depolymerization is strongly inhibited by SipAC.

Download video file (1.6MB, avi)
2

Data Availability Statement

The cryo-EM map of SipAC/F-actin has been deposited with accession code EMD-42161 in the EMDB. The coordinates used for EM analysis have been deposited in the PDB with accession code 8UEE. This paper does not report original code. Any additional information required to reanalyze the data reported in this work is available from the lead contact upon request.

RESOURCES